Obieche Obumneke A, Odili Valentine U
Department of Clinical Pharmacy and Pharmacy Practice, University of Benin, Benin City, Edo State, Nigeria.
Malariaworld J. 2016 Sep 16;7:12. doi: 10.5281/zenodo.10818212. eCollection 2016.
Malaria remains a disease of immense clinical and economic significance. Limited research has been carried out to estimate malaria treatment costs at the health care facility level using the patient's perspective. The objectives of this study were therefore to determine the direct and indirect costs of malaria treatment among adult outpatients and to assess the patients' perception of treatment costs.
A cr oss-sectional study was conducted at the Pharmacy section of the General Practice Clinic, University of Benin Teaching Hospital, Benin City, Edo State, Nigeria. It involved adult outpatients diagnosed with malaria and who received a prescription of one or more anti-malarial medications. A cost-of-illness approach was employed in the assessment of costs of treatment of malaria per sick adult patient. Pre-tested semi-structured questionnaires were used in the study. Furthermore, self-reported incidence of malaria per year was assessed.
The mean direct and indirect cost of tr eating malaria illness per adult outpatient was Nigerian Naira (NGN) 3417.70 ($ 20.34) and NGN 4870 ($ 29.0), respectively, giving a ratio of 0.7:1. Medications and laboratory tests for detection of malaria parasites contributed about 52 and 22% of the total direct cost, respectively. A total of 1592 malaria episodes were self-reported to occur annually, giving a mean value of 3.35 episodes per adult. Having a health care insurance was associated with the response that the cost of malaria treatment was low (< 0.001).
The mean values of direct cost and indirect cost of treatment of malaria illness per adult outpatient were $ 20.34 and $ 29.0, respectively. Respondents who had health insurance perceived malaria treatment cost to be low, whereas those without such insurance felt otherwise.
疟疾仍然是一种具有重大临床和经济意义的疾病。从患者角度估算医疗机构层面疟疾治疗成本的研究有限。因此,本研究的目的是确定成年门诊患者疟疾治疗的直接和间接成本,并评估患者对治疗成本的认知。
在尼日利亚江户州贝宁城贝宁大学教学医院综合诊疗所药房进行了一项横断面研究。研究对象为被诊断患有疟疾并接受一种或多种抗疟药物处方的成年门诊患者。采用疾病成本法评估每位成年患病患者的疟疾治疗成本。研究中使用了经过预测试的半结构化问卷。此外,还评估了每年自我报告的疟疾发病率。
每位成年门诊患者治疗疟疾疾病的平均直接成本和间接成本分别为3417.70尼日利亚奈拉(20.34美元)和4870尼日利亚奈拉(29.0美元),比例为0.7:1。检测疟原虫的药物和实验室检查分别占总直接成本的约52%和22%。每年共自我报告发生1592次疟疾发作,成年患者平均发作次数为3.35次。拥有医疗保险与认为疟疾治疗成本低的回答相关(<0.001)。
每位成年门诊患者治疗疟疾疾病的直接成本和间接成本平均值分别为20.34美元和29.0美元。有医疗保险的受访者认为疟疾治疗成本低,而没有医疗保险的受访者则不然。